Investor mix
4 investors on record; lead investors include One Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Accelerator & incubator | 1 | 25% |
| Bank & private debt | 1 | 25% |
Developer of immunomodulatory drugs to treat immune diseases
4 investors on record; lead investors include One Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 50% |
| Accelerator & incubator | 1 | 25% |
| Bank & private debt | 1 | 25% |